Pacira BioSciences awarded inducement grants to 10 new employees, including stock options for 9,200 shares and restricted stock units for 18,200 shares, as part of its Amended 2014 Inducement Plan. These awards, approved by the company's compensation committee without shareholder approval, aim to attract talent by offering equity with multi-year vesting schedules. The stock options have a 10-year term and an exercise price set at $25.39 per share, the closing price on the grant date. This move supports Pacira's growth in non-opioid pain therapies and aligns employee incentives with company performance.
Quest Software has obtained FedRAMP High authorization for its Quest Identity Defense and Quest Identity Recovery products on Microsoft Azure Government, making it the only provider with a FedRAMP High SaaS offering for hybrid Active Directory and Mi...
Medallion Financial Corp., a specialty finance company, will announce its financial results for the quarter ending June 30, 2026, after market close on July 29, 2026. A conference call to discuss these results is scheduled for July 30 at 9:00 a.m. ET...
Zhibao Technology Inc. has expanded its digital insurance ecosystem by deploying its proprietary low-affinity insurance solution on Chengdu's Tianfu Citizen's Cloud platform, which serves nearly 20 million users. This beta launch, part of a three-yea...
BNB Chain announced a new Layer 1 blockchain focused on agentic trading and AI applications, targeting over 100,000 transactions per second with reduced front-running risks. The testnet is expected by late 2026, with mainnet launch in early 2027. Thi...
Ripple's XRP has partnered with Kansas Athletics, marking the first crypto brand sponsorship on a major college athletics uniform. This move highlights growing crypto integration in NCAA sports, following trends started by FTX in 2021. Despite XRP's ...
